CIRS is associated with the obesity epidemic and leptin resistance; leptin binds to gp130 cytokine receptor in hypothalamus to activate POMC (pro-opiomelanocortin) production of MSH; leptin resistance blocks MSH production, causing fatigue, pain, and obesity. The combination of obesity, leptin resistance, and MSH deficiency is particularly severe; molecular hypometabolism compounds the problem. If 40% of Americans become morbidly obese by 2030, and if CIRS affects 25% of the population, there is massive overlap producing a metabolic catastrophe.